REDHAWK NAMES DR. DREW PINSKY AS NATIONAL SPOKESPERSON
Media Contact:
Julie Calzone
(337) 235-2924
jcalzone@calzone.com
Company Contacts:
G. Darcy Klug, Chairman, CEO and CFO
(337) 269-5933
darcy.klug@redhawkholdingscorp.com
Lafayette, LA -- July 25, 2019 -- InvestorsHub NewsWire -- RedHawk Holdings Corp. (OTC: IDNG) (the "Company" or "RedHawk"), announced today that Dr. Drew Pinsky (commonly known as "Dr. Drew") has agreed to become the Company's exclusive spokesperson for its Sharps and Needle Destruction Device ("SANDD") mini™ and its SANDD Pro™ needle incineration devices (collectively the "SANDD™ Products") and any related products and/or accessories.
Dr. Drew is a private practice physician, an internist, addiction medicine specialist and media personality. He has an undergraduate degree in biology from Amherst College and earned his Doctor of Medicine degree from the University of Southern California School of Medicine. He served his residency in internal medicine at USC County Hospital and became chief resident at Huntington Memorial Hospital in Pasadena, California before moving into private practice.
The SANDD mini™ (formerly known as The Disintegrator™) is a portable, lithium-ion battery operated, needle destruction device primarily for use by self-injector diabetics in the home. In clinical settings, the SANDD mini™ can be used by allergist, dermatologist, cosmetologist, plastic surgeons and other medical specialists without the need for sharps containers for needle disposal. The SANDD mini™ provides diabetics with the safe and environmentally friendly disposal of needles following their use in a home setting and is an effective alternative to hazardous waste needle disposal utilizing sharps containers. The SANDD mini™ is the only FDA-approved portable, battery-operated needle destruction device that eliminates the use of sharps containers for disposal in both clinical and home settings.
The SANDD Pro™ is capable of incinerating hypodermic needles 18-gauge and higher, up to 8 inch in length. Additionally, SANDD Pro™ technology is expected to feature a portable, rechargeable, lithium-ion battery operated unit. RedHawk believes that this portable unit (the "SANDD Pro™ - Portable") will incinerate as many as 300 needles, ranging in gauges as thick as 21 gauge and lengths up to 8" on a single charge. RedHawk expects that the SANDD Pro™ - Portable will be ideal for field use by first responders, home health care nurses, veterinarians and home use injectors. The SANDD Pro™ is both FDA approved and OSHA compliant.
The complete line of SANDD™ products is expected to be available for virtually all home and commercial applications including hospitals, first responders, a full range of clinics and primary care physicians, dentists, veterinarians, retirement and non-acute healthcare facilities. The SANDD mini™ is currently being sold to the general public and to various Independent School Districts in the State of Texas. The Company has stated that it expects to begin offering the SANDD mini™ to various Independent School Districts in the State of California before the end of 2019. The Company also intends to immediately begin to develop and initiate a social media marketing campaign of the sale of the SANDD mini™ to the general public.
